ArticleGenes and immunity2019

The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis.

Laura Watts et al.PubMed ↗Publisher ↗

No numbers read from the abstract.